GEORGE A. JOULWAN

Insider Reports History

Signature
/s/ S. Scott Lieberman, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GEORGE A. JOULWAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 40,244 $73,244 $1.82 26 May 2022 Direct

Insider Reports Filed by GEORGE A. JOULWAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 26 May 2022 1 $0 4 Director 31 May 2022, 16:20
EBS Emergent BioSolutions Inc. 20 May 2021 1 $0 4 Director 24 May 2021, 17:03